PROK ProKidney Corp

Price (delayed)

$3.22

Market cap

$942.5M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.6

Enterprise value

$848.07M

Highlights
ProKidney's equity has increased by 9% YoY
ProKidney's debt has decreased by 43% YoY but it has increased by 4.1% from the previous quarter
The EPS has declined by 5% year-on-year but it has increased by 3.2% since the previous quarter
The net income has dropped by 94% year-on-year and by 12% since the previous quarter
PROK's quick ratio is down by 41% YoY

Key stats

What are the main financial stats of PROK
Market
Shares outstanding
292.7M
Market cap
$942.5M
Enterprise value
$848.07M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1,357.2
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2,771.46
Earnings
Revenue
$306,000
Gross profit
$306,000
Operating income
-$184.99M
Net income
-$68.43M
EBIT
-$68.53M
EBITDA
-$62.6M
Free cash flow
-$150.98M
Per share
EPS
-$0.6
EPS diluted
-$0.6
Free cash flow per share
-$1.17
Book value per share
-$3.41
Revenue per share
$0
TBVPS
$3.15
Balance sheet
Total assets
$406.06M
Total liabilities
$36.08M
Debt
$3.37M
Equity
-$998.55M
Working capital
$326.85M
Liquidity
Debt to equity
0
Current ratio
10.96
Quick ratio
10.01
Net debt/EBITDA
1.51
Margins
EBITDA margin
-20,456.2%
Gross margin
100%
Net margin
-22,362.1%
Operating margin
-60,453.6%
Efficiency
Return on assets
-15%
Return on equity
N/A
Return on invested capital
-22.7%
Return on capital employed
-18.4%
Return on sales
-22,394.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PROK stock price

How has the ProKidney stock price performed over time
Intraday
5.57%
1 week
-13.67%
1 month
431.35%
1 year
37.61%
YTD
90.53%
QTD
443.83%

Financial performance

How have ProKidney's revenue and profit performed over time
Revenue
$306,000
Gross profit
$306,000
Operating income
-$184.99M
Net income
-$68.43M
Gross margin
100%
Net margin
-22,362.1%

PROK financials

The net income has dropped by 94% year-on-year and by 12% since the previous quarter
ProKidney's operating margin has surged by 75% QoQ
ProKidney's net margin has soared by 72% from the previous quarter
ProKidney's operating income has decreased by 23% YoY

Price vs fundamentals

How does PROK's price correlate with its fundamentals

PROK Price vs fundamentals

PROK Earnings waterfall

PROK Price vs fair value

Growth

What is ProKidney's growth rate over time

PROK growth chart

Valuation

What is ProKidney stock price valuation
P/E
N/A
P/B
N/A
P/S
1,357.2
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2,771.46

Valuation vs average

Price to earnings (P/E)

The EPS has declined by 5% year-on-year but it has increased by 3.2% since the previous quarter

Price to book (P/B)

ProKidney's equity has increased by 9% YoY

Price to sales (P/S)

Efficiency

How efficient is ProKidney business performance
The return on invested capital has dropped by 103% year-on-year and by 12% since the previous quarter
The return on assets has dropped by 85% year-on-year and by 10% since the previous quarter
The return on sales has surged by 72% since the previous quarter

Dividends

What is PROK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PROK.

Financial health

How did ProKidney financials performed over time

Assets vs liabilities

ProKidney's total liabilities has increased by 46% YoY but it has decreased by 8% QoQ
PROK's quick ratio is down by 41% YoY

Debt vs equity

ProKidney's debt is 100% more than its equity
The debt to equity has soared by 100% year-on-year
ProKidney's debt has decreased by 43% YoY but it has increased by 4.1% from the previous quarter

Balance sheet

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.